JND Banner MadMimi
 

Please feel free forward to your colleagues and share the news of our journal

JND MadMimi lijn2

NEW ISSUE

Volume 7, Issue 4 / 2020 Now Available Online

REVIEW ARTICLES
Towards Central Nervous System Involvement in Adults with Hereditary MyopathiesOpen Access
Reimann, Jens | Kornblum, Cornelia

Induction of Skeletal Muscle Progenitors and Stem Cells from human induced Pluripotent Stem CellsOpen Access
Sato, Takahiko

RESEARCH ARTICLES
Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study
Batra, Abhinandan | Lott, Donovan J. | Willcocks, Rebecca | Forbes, Sean C. | Triplett, William | Dastgir, Jahannaz | Yun, Pomi | Reghan Foley, A. | Bönnemann, Carsten G. | et al.

Ganglionopathies Associated with MERRF Syndrome: An Original Report
Michaud, Maud | Stojkovic, Tanya | Maisonobe, Thierry | Behin, Anthony | Rucheton, Benoit | Léonard-Louis, Sarah | Eymard, Bruno | Laforêt, Pascal

Respiratory Dysfunction in Becker Muscular Dystrophy Patients: A Case Series and Autopsy Report
Mori-Yoshimura, Madoka | Oya, Yasushi | Komaki, Hirohumi | Segawa, Kazuhiko | Minami, Narihiro | Saito, Yuko | Nishino, Ichizo | Takahashi, Yuji

Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy
Naarding, Karin J. | Doorenweerd, Nathalie | Koeks, Zaïda | Hendriksen, Ruben G.F. | Chotkan, Kinita A. | Krom, Yvonne D. | de Groot, Imelda J.M. | Straathof, Chiara S. | Niks, Erik H. | Kan, Hermien E.

Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations
Vázquez, José | Lefeuvre, Claire | Escobar, Rosa Elena | Luna Angulo, Alexandra Berenice | Miranda Duarte, Antonio | Delia Hernandez, Alma | Brisset, Marion | Carlier, Robert-Yves | et al.

Natural History of Type 1 Spinal Muscular Atrophy in a Series of Argentinian Children
Aguerre, V. | De Castro, F. | Mozzoni, J. | Gravina, LP. | Araoz, HV. | Monges, S.

Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy
Rodriguez-Torres, Rafael | Fabiano, Julia | Goodwin, Ashley | Rao, Ashwini K. | Kinirons, Stacy | De Vivo, Darryl | Montes, Jacqueline

Facilitators and Barriers to Wearing Hand Orthoses by Adults with Duchenne Muscular Dystrophy: A Mixed Methods Study DesignOpen Access
Houwen-van Opstal, S.L.S. | van den Elzen, Y.M.E.M. | Jansen, M. | Willemsen, M.A.A.P. | Cup, E.H.C. | De Groot, I.J.M.

JND MadMimi lijn2

Special issue dedicated to studies where the results do not support the intervention tested and yet generate very useful data for the field

Testing if a hypotheses is correct or not is the way science advances, but pressure to publish has resulted in researchers preferentially publishing studies that disprove the null hypothesis: reporting on an effect is much more common than a lack of it. This is particularly evident in translational research, where potential therapies are evaluated in model systems or patients. The neuromuscular field is aware of a publication bias towards therapeutic approaches that appear to have beneficial effects in model systems and patients. Failure to publish studies where therapies are not beneficial, toxic or results are not reproducible, not only impedes science and therapy development, it also leads to unnecessary duplication of efforts and a waste of resources.

We now seek papers for a special issue on this topic, dedicated to those studies where results were not as anticipated or hoped for. The World Duchenne Organisation (WDO) has generously offered to cover Open Access fees for publications related to dystrophinopathies in this special issue due to sponsorship of Parent Project Muscular Dystrophy (PPMD) and Duchenne Parent Project Netherlands. WDO will select some of these publications for further awards.

Contact: Annemieke Aartsma-Rus (details available via the link below)

More details here (PDF link)

JND MadMimi lijn2

Most Read JND Articles in August 2020

Listing articles published only in 2019 and 2020 so you can read the most popular recent content

Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for CareOpen Access (Review Article in Vol.7, Iss.1, 2020)
Schorling, David C. | Pechmann, Astrid | Kirschner, Janbernd

AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History CohortOpen Access (Research Article in Vol.6, Iss.3, 2019)
Al-Zaidy, Samiah A. | Kolb, Stephen J. | Lowes, Linda | Alfano, Lindsay N. | Shell, Richard | Church, Kathleen R. | Nagendran, Sukumar | Sproule, Douglas M. | et al.

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful OutcomeOpen Access (Case Report in Vol.7, Iss.3, 2020)
Ramaswamy, Swathi Beladakere | Govindarajan, Raghav

A Mutation in the Mitochondrial Aspartate/Glutamate Carrier Leads to a More Oxidizing Intramitochondrial Environment and an Inflammatory Myopathy in Dutch Shepherd DogsOpen Access (Research Article in Vol.6, Iss.4, 2019)
Shelton, G. Diane | Minor, Katie M. | Li, Kefeng | Naviaux, Jane C. | Monk, Jon | Wang, Lin | Guzik, Elizabeth | Guo, Ling T. | Porcelli, Vito | Gorgoglione, Ruggiero | Lasorsa, Francesco M. | et al.

Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 – A Prospective Observational StudyOpen Access (Research Article in Vol.6, Iss.4, 2019)
Walter, Maggie C. | Wenninger, Stephan | Thiele, Simone | Stauber, Julia | Hiebeler, Miriam | Greckl, Eva | Stahl, Kristina | Pechmann, Astrid | Lochmüller, Hanns | et al.

One Year of Newborn Screening for SMA – Results of a German Pilot ProjectOpen Access (Research Article in Vol.6, Iss.4, 2019)
Vill, Katharina | Kölbel, Heike | Schwartz, Oliver | Blaschek, Astrid | Olgemöller, Bernhard | Harms, Erik | Burggraf, Siegfried | Röschinger, Wulf | Durner, Jürgen | et al.

JND MadMimi lijn2

TREAT-NMD News

SMA Outcome Measure Library

The Spinal Muscular Atrophy (SMA) Outcome Measure Library has been developed as a quick reference tool to help patient registries in the TREAT-NMD Network choose and implement the right outcome measures for their patients.

The TREAT-NMD SMA Dataset team has produced this reference tool, which includes all validated outcome measures currently in use for SMA. The aim of this resource is to support independent decision-making on which outcome measure is most suitable for the individual being assessed. Users of the Outcome Measure Library are welcome to provide feedback on its usefulness, any missing information or any additional outcome measures or PROMS, used for SMA, that should be included. Feedback can be provided by completing this online feedback form.

The Outcome Measure Library is publicly available on the TREAT-NMD website.

JND MadMimi lijn2

Upcoming Event

CONY 2020 Virtual

Oct 29–Nov 1, 2020 | Online

The 14th World Congress on Controversies in Neurology (CONy), which was due to take place in London earlier this year but had to be postponed due to the current pandemic, has now transitioned to a virtual event. A fully online conference across 4 days will start on October 29, 2020. CONy's virtual platform will see delegates engaging with the industry, expanding knowledge, and broadening the learning opportunities in an online environment. Plus, the organizers are offering free registration for all! Get further information and program details at the event website here.

JND MadMimi lijn2

Sign Ups & Social Media

Help Spread the News of JND!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the sign-up link at the bottom of this email or access here.

If you are not yet interacting with JND on social media, why not take the time today to follow us on Twitter and find us on Facebook?

Be part of the discussion!

JND MadMimi lijn2
JND cover klein

Indexed in: PubMed/MEDLINE Scopus

Submit your Paper

As a member of our research community, we would like to invite you to contribute your own articles to the journal. JND offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an affordable Open Access option (€1250/US$1450). JND is fully compliant with all mandates by major funders, and Open Access articles are automatically uploaded to PubMed Central. More reasons to publish in JND are outlined on the journal's website!

Submit your manuscript online via MsTracker
View detailed Instructions to Authors
Aims and Scope

JND MadMimi lijn2
***

You are receiving this mailing as you are signed up to receive news from JND.
You can unsubscibe or alter your preferences at any time by clicking the links below
.

 
 
Powered by Mad Mimi®A GoDaddy® company